Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 6/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.38 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 9/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 9/20 | 0.35 |
| ▸ | MAN1B1 | Q9UKM7 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.31 |
| ▸ | CHRNG | P07510 | 2/20 | 0.31 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.31 |
| ▸ | CHRND | Q07001 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26976760 | 0.97 | CHRNB4 (0.36) | CHRNB4CHRNA3CCR5CHRNB2CHRNA4 | |
| SCHEMBL7527940 | 0.87 | — | — | |
| SCHEMBL30741886 | 0.87 | — | — | |
| SCHEMBL27115171 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL25259741 | 0.84 | CHRNB4 (0.33) | CHRNB4CHRNA3CCR5CHRNB2CHRNA4 | |
| SCHEMBL9636603 | 0.82 | SMN1; SMN2 (0.33) | CHRNB4CHRNA3CHRNB2CHRNA4HTR3A | |
| SCHEMBL14529644 | 0.82 | DAO (0.37) | CHRNB4CHRNA3CHRNB2CHRNA4HTR3A | |
| SCHEMBL22965580 | 0.82 | SMN1; SMN2 (0.33) | CHRNB4CHRNA3CHRNB2CHRNA4HTR3A | |
| Hydrochloric Acid SCHEMBL14335830 | 0.80 | CHRNB2 (0.33) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL9585542 | 0.80 | CHRNB4 (0.31) | CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570851-B2 | Liquids | MILLIKEN INDUSTRIALS LIMITED (GB) | 2026-03-10 | — | — | US | disclosed |
| EP-4596564-A1 | METHOD FOR PREPARING A HOMOGENEOUS SOLUTION OF A METAL BISPIDONE CHELATE COMPLEX FOR OXIDATIVELY DRYING SYSTEMS | hubergroup Deutschland GmbH (DE) | 2025-08-06 | — | — | EP | disclosed |
| US-12077652-B2 | Oxidatively curable coating composition | MILLIKEN INDUSTRIALS LIMITED (GB) | 2024-09-03 | — | — | US | disclosed |
| EP-4172283-A1 | PAINTS CONTAINING DRIERS BASED ON VANADIUM COMPOUNDS BEARING ANIONS OF SULFONIC ACIDS AS COUNTER IONS | Borchers GmbH (DE) | 2023-05-03 | — | — | EP | disclosed |
| US-20220073735-A1 | LIQUIDS | Borchers Catalyst (UK) Limited (GB) | 2022-03-10 | — | — | US | disclosed |
| US-20220073701-A1 | OXIDATIVELY CURABLE COATING COMPOSITION | CATEXEL TECHNOLOGIES LIMITED (GB) | 2022-03-10 | — | — | US | disclosed |
| EP-3818116-A1 | OXIDATIVELY CURABLE COATING COMPOSITION | Catexel Technologies Limited (GB) | 2021-05-12 | — | — | EP | disclosed |
| EP-3818101-A1 | LIQUIDS | Borchers Catalyst (UK) Limited (GB) | 2021-05-12 | — | — | EP | disclosed |
| WO-2020008205-A1 | OXIDATIVELY CURABLE COATING COMPOSITION | CATEXEL TECHNOLOGIES LIMITED (GB) | 2020-01-09 | — | — | WO | disclosed |
| WO-2020008203-A1 | LIQUIDS | CATEXEL LIMITED (GB) | 2020-01-09 | — | — | WO | disclosed |
| US-5468858-A | Sudden death syndrome | THE BOARD OF REGENTS OF OKLAHOMA STATE UNIVERSITY PHYSICAL SCIENCES (US) | 1995-11-21 | — | — | US | disclosed |
| EP-0618881-A4 | A PROCESS FOR PREPARING MOLECULAR SIEVES USING 3,7-DIAZABICYCLO[3.3.1]NONANE TEMPLATES. | CHEVRON RES & TECH (US) | 1995-01-04 | — | — | EP | disclosed |
| EP-0618881-A1 | A PROCESS FOR PREPARING MOLECULAR SIEVES USING 3,7-DIAZABICYCLO[3.3.1]NONANE TEMPLATES | CHEVRON RESEARCH AND TECHNOLOGY COMPANY, (US) | 1994-10-12 | — | — | EP | disclosed |
| WO-1994008898-A1 | A PROCESS FOR PREPARING MOLECULAR SIEVES USING 3,7-DIAZABICYCLO[3.3.1]NONANE TEMPLATES | CHEVRON RESEARCH AND TECHNOLOGY COMPANY, A DIVISIO (US) | 1994-04-28 | — | — | WO | disclosed |
| US-5271921-A | Process for preparing molecular sieves using 3,7-diazabicyclo[3.3.1] | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1993-12-21 | — | — | US | disclosed |
| US-5268481-A | Containing a benzene ring | BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECHANICAL COLLEGE ACTING FOR AND ON BEHALF OF OKLAHOMA STATE UNIVERSITY (US) | 1993-12-07 | — | — | US | disclosed |
| US-5043445-A | Bis-1,3-diazine heterocyclic derivatives as antiarrhythmic agents | OKLAHOMA STATE UNIVERSITY (US) | 1991-08-27 | — | — | US | disclosed |
| US-4980468-A | ANTIARRHYTHMIC AGENTS | BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECHANICAL COLLEGES ACTING FOR AND ON BEHALF OF OKLAHOMA STATE UNIVERSITY (US) | 1990-12-25 | — | — | US | disclosed |
| US-4910311-A | Containing a phenyl or thiophene ring | BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL MECHANICAL COLLEGES, ACTING FOR AND ON BEHALF OF OKLAHOMA STATE UNIV. (US) | 1990-03-20 | — | — | US | disclosed |
| US-4778892-A | Certain 3-selena-7-aza-bicyclo[3.3.1]nonanes as antiarrhythmic agents | OKLAHOMA STATE UNIVERSITY (US) | 1988-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570851-B2 | Liquids | SOD1, GPX4, SMARCC1 | CHRNB4 3686/4885CHRNA3 2740/4885CCR5 1131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.